TMX2 potentiates cell viability of hepatocellular carcinoma by promoting autophagy and mitophagy.

ABSTRACT

The dysregulation of membrane protein expression has been implicated in tumorigenesis and progression, including hepatocellular carcinoma (HCC). In this study, we aimed to identify membrane proteins that modulate HCC viability. To achieve this, we performed a CRISPR activation screen targeting human genes encoding membrane-associated proteins, revealing TMX2 as a potential driver of HCC cell viability. Gain- and loss-of-function experiments demonstrated that TMX2 promoted growth and tumorigenesis of HCC. Clinically, TMX2 was an independent prognostic factor for HCC patients. It was significantly upregulated in HCC tissues and associated with poor prognosis of HCC patients. Mechanistically, TMX2 was demonstrated to promote macroautophagy/autophagy by facilitating KPNB1 nuclear export and TFEB nuclear import. In addition, TMX2 interacted with VDAC2 and VADC3, assisting in the recruitment of PRKN to defective mitochondria to promote cytoprotective mitophagy during oxidative stress. Most interestingly, HCC cells responded to oxidative stress by upregulating TMX2 expression and cell autophagy. Knockdown of TMX2 enhanced the anti-tumor effect of lenvatinib. In conclusion, our findings emphasize the pivotal role of TMX2 in driving the HCC cell viability by promoting both autophagy and mitophagy. These results suggest that TMX2 May serve as a prognostic marker and promising therapeutic target for HCC treatment.Abbreviation CCCP Carbonyl cyanide 3-chlorophenylhydrazone; Co-IP co-immunoprecipitation; CRISPR clustered regularly interspaced short palindromic repeat; ER endoplasmic reticulum; HCC hepatocellular carcinoma; KPNB1 karyopherin subunit beta 1; PRKN parkin RBR E3 ubiquitin protein ligase; ROS reactive oxygen species; TFEB transcription factor EB; TMX2 thioredoxin related transmembrane protein 2; VDAC2 voltage dependent anion channel 2; VDAC3 voltage dependent anion channel 3; WB western blot.